Study may aid U.S. approved of ImClone cancer drug Erbitux
Erbitus, the cancer drug from ImClone Systems Inc., helps fight colon cancer, according to an independent review of highly anticipated trial. The trial sponsored by Merck KgaA, ImClone's European